mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |